Key figures
In the table below, you can find Oriola's key figures. Read our financial reports to find out more.
|
Key figures |
2025 |
2025 |
2024 |
2024 |
|
EUR million |
Restated |
|
Restated |
|
|
Invoicing |
4,201.2 |
4,201.2 |
3,771.8 |
3,771.8 |
|
Net sales |
201.6 |
1,906.2 |
200.0 |
1,679.7 |
|
Adjusted EBITDA |
35.1 |
35.1 |
33.4 |
33.4 |
|
EBITDA |
20.3 |
20.3 |
27.2 |
27.2 |
|
Adjusted EBITDA % |
17.4 |
1.8 |
16.7 |
2.0 |
|
EBITDA % |
10.1 |
1.1 |
13.6 |
1.6 |
|
Profit for the period |
-27.2 |
-27.2 |
-20.1 |
-20.1 |
|
Earnings per share, EUR |
-0.15 |
-0.15 |
-0.11 |
-0.11 |
|
Net cash flow from operating activities |
60.0 |
60.0 |
38.7 |
38.7 |
|
Free cash flow |
58.4 |
58.4 |
43.4 |
43.4 |
|
Gearing, % |
-81.4 |
-81.4 |
-28.0 |
-28.0 |
|
Equity ratio, % |
13.1 |
10.8 |
18.7 |
15.4 |
|
Return on capital employed (ROCE), % |
1.3 |
1.3 |
5.4 |
5.4 |
|
|
|
|
|
|
|
Numbers above include dose dispensing Sweden |
|
|
|
|
|
Net sales |
6.0 |
6.0 |
21.7 |
21.7 |
|
Adjusted EBITDA |
0.2 |
0.2 |
0.1 |
0.1 |
|
EBITDA |
-2.5 |
-2.5 |
1.6 |
1.6 |
1 Adjusting items are specified in note Adjusting items.